Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Switching From Natalizumab to Ocrelizumab in Patients With Multiple SclerosisMult. Scler. 2020 Jun 19;[EPub Ahead of Print], SN Levin, C Ezuma, L Levine, WS Vargas, RS Farber, PL De Jager, CS Riley
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.